Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 6.605\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) Cc1cc(NC(=O)CSc2nnc(-c3ccc4c(c3)OCCO4)o2)no1
(b) CCCNC(=O)C1CN(C(=O)c2nn(Cc3ccccc3)c(=O)c3ccccc23)c2ccccc2O1
Answer: b. CCCNC(=O)C1CN(C(=O)c2nn(Cc3ccccc3)c(=O)c3ccccc23)c2ccccc2O1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCNC(=O)C1CN(C(=O)c2nn(Cc3ccccc3)c(=O)c3ccccc23)c2ccccc2O1
CCCNC(=O)C1CN(C(=O)c2nn(Cc3ccccc3)c(=O)c3ccccc23)c2ccccc2O1
4-(3-benzyl-4-oxophthalazine-1-carbonyl)-N-propyl-2,3-dihydro-1,4-benzoxazine-2-carboxamide